Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0000950170-23-062216
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $1.30M | $1.57M | $2.38M | $314.00K |
| Net Income | -$2.57M | -$2.87M | -$2.18M | -$6.39M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$1.89 |
| -$4.67 |
| -$0.10 |
| -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.